Retractable Protein Nanoneedles The ability to control the transfer of molecules through cellular membranes is an important function in synthetic biology; a new study from researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering and Harvard Medical School (HMS) introduces a novel mechanical method for controlling release of molecules inside cells.Advancing Synthetic Biology Living systems rely on a dizzying variety of chemical reactions essential to development and survival. Most of these involve a specialized class of protein molecules — the enzymes.Insights into the Function of the Main Class of Drug Targets About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.Honey’s Potential to Save Lives The healing powers of honey have been known for thousands of years. Muscles on-a-Chip This study may help explain why stem cell-based therapies have so far shown limited benefits for heart attack patients in clinical trials.3-D Printed Lifelike Liver Tissue for Drug Screening A team led by engineers at the University of California, San Diego has 3D-printed a tissue that closely mimics the human liver's sophisticated structure and function. The new model could be used for patient-specific drug screening and disease modeling. Envigo Rat Models Proven to be Susceptible to Intra-Vaginal HSV-2 Infection and Protectable Scientific findings establish the effectiveness of new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection.Valvena, GSK Sign New R&D Collaboration Valneva to supply process development services for EB66® -based Influenza vaccines. Food Triggers Creation of Regulatory T Cells IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.Counting Cancer-busting Oxygen Molecules Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Polymeric Nanoparticles for Oral Chemotherapy Maite Agueros Bazo, Postdoc Researcher, University of Navarra, speaking at Nanomedicine 2013.
PASylation: the Biological Alternative to PEGylation Uli Binder, XL Protein GmbH, speaking at Discovery Chemistry Congress 2013.
Tumour Regression After Intravenous Administration of Novel Tumour-targeted Nanomedicines Christine Dufes, Senior Lecturer in Drug Delivery, University of Strathclyde, speaking at Nanomedicine 2013.
Helping you to shape in vitro models with cell-based assays Christian Oberdanner, Ph.D. Marketing Application Specialist Detection for Tecan Austria
Microelectronics Meets Microfluidics: Hybrid Integration of Sensors in Microfluidic Devices Holger Becker, Microfluidic ChipShop GmbH, speaking at Lab-on-a-Chip World Congress 2012
Biopharmaceutical Evaluation of Poorly Soluble Drugs and Enabling Formulations Professor Martin Brandl, University of Southern Denmark, speaking at Discovery Chemistry Congress 2013.
Cationic Nanoparticles for Cancer Chemotherapy Erem Bilensoy, Associate Professor, Hacettepe University Faculty of Pharmacy, speaking at Nanomedicine Europe 2013.
Improved Uptake of Drugs for Cancer Treatment by Cyclodextrin Carriers Gerhard Wenz, University of Saarland, speaking at Discovery Chemistry Congress 2013.
Enhancing Drug Solubility through Phrase Separation/Coacervation and Spray Drying Kamal Jonnalagadda, University of the Sciences in Philadelphia, speaking at Discovery Chemistry Congress 2013.